In dogs and cats, methocarbamol is indicated (FDA approved) as a adjunctive therapy of acute inflammatory and traumatic conditions of the skeletal muscle and to reduce muscular spasms. In horses, intravenous use is indicated (FDA approved) as a adjunctive therapy of acute inflammatory and traumatic conditions of the skeletal muscle to reduce muscular spasms, and effect striated muscle relaxation.